0001209191-23-045705.txt : 20230814 0001209191-23-045705.hdr.sgml : 20230814 20230814182324 ACCESSION NUMBER: 0001209191-23-045705 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230810 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Frankenius Equity AB CENTRAL INDEX KEY: 0001988262 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39813 FILM NUMBER: 231172541 BUSINESS ADDRESS: STREET 1: BOX 984 CITY: BORAS STATE: V7 ZIP: SE-501 10 BUSINESS PHONE: 46 (0) 705-27 13 50 MAIL ADDRESS: STREET 1: BOX 984 CITY: BORAS STATE: V7 ZIP: SE-501 10 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TriSalus Life Sciences, Inc. CENTRAL INDEX KEY: 0001826667 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 853009869 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6272 WEST 91ST AVENUE CITY: WESTMINSTER STATE: CO ZIP: 80031 BUSINESS PHONE: 415 336 8917 MAIL ADDRESS: STREET 1: 6272 WEST 91ST AVENUE CITY: WESTMINSTER STATE: CO ZIP: 80031 FORMER COMPANY: FORMER CONFORMED NAME: MedTech Acquisition Corp DATE OF NAME CHANGE: 20200930 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2023-08-10 0 0001826667 TriSalus Life Sciences, Inc. TLSI 0001988262 Frankenius Equity AB BOX 984 BORAS V7 SE-501 10 SWEDEN 0 0 1 0 Common Stock 6167776 D Series A Convertible Preferred Stock 10.00 Common Stock 230000 D The securities reported herein were acquired by the Reporting Person in connection with the Merger (as defined in that certain Agreement and Plan of Merger, dated as of November 11, 2022, as amended, by and among the Issuer, MTAC Merger Sub, Inc., and TriSalus Operating Life Sciences, Inc.) The Series A Convertible Preferred Stock ("Preferred Stock") is convertible, in whole or in part, into 230,000 shares of Common Stock of the Issuer (based on an initial conversion price of $10.00 per share, which is subject to adjustment upon the occurrence of certain events, the "Conversion Price") at any time, at the Reporting Person's election. The number of shares of the Issuer's Common Stock received per share of Preferred Stock upon conversion equals the sum of (A) $10.00 (as adjusted upon the occurrence of certain events) and (B) any accrued, unpaid annual dividends, divided by the Conversion Price, with cash in-lieu of fractional shares. All then outstanding shares of Preferred Stock are automatically converted into shares of the Issuer's Common Stock on August 10, 2027. /s/ ULRIKA JORETEG 2023-08-14